Reinsurance Group of America fielded investor questions during its third-quarter earnings call that centered on newly refined mortality assumptions now rippling through the company’s balance sheet and informing its future go-to-market strategy.
Chief Risk Officer Jonathan Porter told analysts the company had recently “increased our expectation for future U.K. mortality, and that’s resulted in an increase in future mortality claims and an offsetting decrease to future longevity claims.”
He added that the change reflects “ongoing excess mortality we’re seeing in the U.K. population, which likely reflects challenges with the UK' s National Health System as well as a thorough review of recent experience in our own book of business.”
